• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Communication, Education, and Radiological Programs (OCER) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 20118592
Nov 20118586
Dec 20118591
Jan 20128592
Feb 20128597
Mar 20128598
Apr 201285100
May 20128597
Jun 20128592
Jul 20128593
Aug 20128595
Sep 20128577

FY 2012 Overall: 93%

Number of OCER intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A11
Nov 2011N/A6
Dec 2011N/A10
Jan 2012N/A33
Feb 2012N/A58
Mar 2012N/A42
Apr 2012N/A23
May 2012N/A32
Jun 2012N/A72
Jul 2012N/A42
Aug 2012N/A53
Sep 2012N/A24

FY 2012 Total: 406

Total number of OCER intra- and inter-Office eConsults completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A12
Nov 2011N/A7
Dec 2011N/A11
Jan 2012N/A36
Feb 2012N/A60
Mar 2012N/A43
Apr 2012N/A23
May 2012N/A33
Jun 2012N/A78
Jul 2012N/A45
Aug 2012N/A56
Sep 2012N/A31

FY 2012 Total: 435

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.